SCHEMBL14366558

SCHEMBL14366558

O=C(c1ccc2[nH]c3c(c2c1)CCCc1cn[nH]c1-3)N1CCC(N2CCCC2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 4/20 0.49
MAPK10 P53779 4/20 0.49
RIPK1 Q13546 2/20 0.49
KDR P35968 1/20 0.49
TLR9 Q9NR96 1/20 0.48
TLR8 Q9NR97 1/20 0.48
TLR7 Q9NYK1 1/20 0.48
CNR1 P21554 1/20 0.48
L3MBTL3 Q96JM7 8/20 0.47
L3MBTL1 Q9Y468 7/20 0.47
CNR2 P34972 1/20 0.47
MBTD1 Q05BQ5 4/20 0.46
TP53BP1 Q12888 2/20 0.46
L3MBTL4 Q8NA19 1/20 0.46
LMNA P02545 3/20 0.46
KDM4E B2RXH2 2/20 0.44
MEN1 O00255 2/20 0.44
ALDH1A1 P00352 2/20 0.44
MAPT P10636 2/20 0.44
MAPK1 P28482 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14366564 0.99 PARP1 (0.50) PARP1MAPK10RIPK1KDRTLR9
SCHEMBL14366570 0.99 PARP1 (0.50) PARP1MAPK10RIPK1KDRTLR9
SCHEMBL14366566 0.99 PARP1 (0.50) PARP1MAPK10RIPK1KDRTLR9
SCHEMBL14366562 0.99 PARP1 (0.50) PARP1MAPK10RIPK1KDRTLR9
Hydrochloric Acid SCHEMBL5583141 0.99 PARP1 (0.49) PARP1MAPK10RIPK1KDRTLR9
Hydrochloric Acid SCHEMBL5582994 0.98 PARP1 (0.49) PARP1MAPK10RIPK1KDRTLR9
Hydrochloric Acid SCHEMBL5582970 0.98 PARP1 (0.49) PARP1MAPK10RIPK1KDRTLR9
Hydrochloric Acid SCHEMBL5583262 0.98 PARP1 (0.49) PARP1MAPK10RIPK1KDRTLR9
Hydrochloric Acid SCHEMBL5583219 0.98 PARP1 (0.49) PARP1MAPK10RIPK1KDRTLR9
SCHEMBL14366595 0.98 PARP1 (0.49) PARP1MAPK10RIPK1KDRTLR9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070254877-A1 Indole Derivative and Use for Treatment of Cancer TAKADA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-11-01 US disclosed
US-20070254877-A1 Indole Derivative and Use for Treatment of Cancer TAKADA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254877-A1 Indole Derivative and Use for Treatment of Cancer IGF1R, KDR, ERBB2 PARP1 1810/4885MAPK10 1222/4885RIPK1 702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.